Worldwide cooperation with universities

Minami Nutrition considers scientific research to be of paramount importance. In 2004 several products - MorEPA®, MorDHA® and PlusEPA®- were included in the following studies :

- in cooperation with the University of Munich, Department of Metabolic Disorders and Nutrition, Prof. Koletsko, Dr E. Severus and Dr Riedel: research into postnatal depression (product: PlusEPA® and a placebo)

- In cooperation with University of Oxford, University Laboratory for Physiology, Prof. Alexandra Richardson: research into dyslexia and ADHD (product: MorEPA® and a placebo)

- In cooperation with the University of Bristol, Department of Experimental Psychology, Prof. Peter Rogers and Dr Katherine Appleton: research into mood swings in women (product: MorDHA® and a placebo)

- In cooperation with the Monash University and Monash Medical Center in Melbourne, Australia, Prof. Krishna Vaddadi: study (product: PlusEPA® and a placebo)

- Placebo controlled, 15 weeks randomised multicenter study of PlusEPA® as treatment for ADHD with co-morbidity in Swedish children ages 7-12 (HPEPA1).
Participating units: Child and Adolescent psychiatric clinics in Uppsala, Karolinska Institute, Linkoping, Kalmar, Section for Pediatric Neurology and Habilitation, Children's Hospital,
Huddinge University Hospital, School Care Unit Örebro.
Each unit provides 18 (at least 8 ) Children.

- In cooperation with the Vrije University, Amsterdam, Dr F. Pouwer, Diabetes Research Group EMGO Institute: research into the relationship between diabetes and depression (product: PlusEPA® and a placebo)

- Study on the Comparison of the therapeutic effect of EPA and fluoxetine in patients with major depression. (product: PlusEPA® and a placebo) in cooperation with School of Public Health and Institute of Public Health Research (SPH-IPHR), Tehran University of Medical Sciences (TUMS) Dr. Seyed Ali Keshavarz , Dr. Mahmood Jalali and Dr. Shima Jazayery.